top of page

Browse by category

Search

GLP-1 implant NPM-115 meets primary endpoint

GLP-1 implant NPM-115 meets primary endpoint

GLP-1 implant NPM-115 meets primary endpoint

Vivani Medical has revealed that results from the LIBERATE-1 clinical study, a Phase 1 study of the exenatide GLP-1 implant NPM-115...

Vivani issues positive preclinical weight loss data for NPM-139 semaglutide implant

Vivani issues positive preclinical weight loss data for NPM-139 semaglutide implant

Vivani issues positive preclinical weight loss data for NPM-139 semaglutide implant

Vivani Medical has announced promising preclinical data for NPM-139, its subdermal semaglutide implant under development for chronic...

First human implant of GLP-1 Implant NPM-115

First human implant of GLP-1 Implant NPM-115

First human implant of GLP-1 Implant NPM-115

Vivani Medical has announced the successful administration of its first GLP-1 (exenatide) implant in the LIBERATE-1 clinical trial,...

OMMs appear to be valid alternatives to EBP and MBS for mild-to-moderate obesity, but surgery more effective for patients with a higher degree of obesity

9 hours ago

MyPhenome test predicts GLP-1 response and obesity risk in large, diverse populations

10 hours ago

Apnimed’s sulthiame's demonstrates efficacy in obstructive sleep apnoea

2 days ago

Back to Top

bottom of page